A recent meta-analysis involving 54,092 participants from seven randomized controlled trials, which included individuals with T2DM and a history of HF (16%), suggested that GLP-1 RAs might help prevent new-onset HF in the diabetic population. The gene discussed is GCG; the disease is type 2 diabetes mellitus.